Boiron Laboratories And The Montreal Canadiens: A Winning Team!
Montreal Canadiens partner with Boiron Laboratories for season 2010-2011
To view this Social Media Release, please enter the following address in your web browser.
http://smr.newswire.ca/en/boiron-laboratories/boiron-laboratories-and-the-montreal-canadiens-a-winning
SAINT-BRUNO-DE-MONTARVILLE, QC, Oct. 19 /CNW Telbec/ - Boiron Laboratories, world leader pharmaceutical laboratory in homeopathy, are proud to announce their partnership with the Montreal Canadiens for season 2010-2011. Partnering with one of the most prestigious institutions in Canada speaks volumes about Boiron's ambition to integrate with and establish themselves as a central figure of the Quebec economic landscape.
This association with the Canadiens recognizes the excellence of the Boiron Laboratories homeopathic medicines and their benefits: effective, non addictive and very safe. This partnership follows a growing trend among consumers for more natural and environment-friendly products and will bring focus on their flagship product OSCILLOCOCCINUM® (OSCILLO), France's top selling over-the-counter flu medicine. OSCILLO works effectively against flu symptoms: chills, fever, muscles aches and headaches. ¨We are proud to join forces with the Montreal Canadiens hockey team and offer consumers a safe and natural medicine," said Majid Djoudi, CEO of Boiron Canada and Pharm. D.
He adds "When a hockey player has an important match to play and shows flu symptoms, taking OSCILLO will relieve his symptoms within 48 hours. With OSCILLOCOCCINUM®, we can all enjoy a healthy winter!"
Tested in many independent clinical studies, OSCILLO has showed to be efficient from the first sign of flu symptoms. This medicine bears a Health Canada Drug Identification Number (DIN) guaranteeing its safety and efficacy. Without side effects or drug interactions, OSCILLO has no contraindications and it will not cause drowsiness. This safe medicine enables patients to recover quickly and remain healthy throughout winter, a major plus for hockey players and athletes. OSCILLO is suitable for all, including pregnant and breastfeeding women, seniors and high-risk patients as well as children.
Moreover, the results of a clinical trial involving 372 flu sufferers published in the British Homeopathic Journal(1), provides clear evidence of Oscillo's efficiency. 62.9% of patients who used OSCILLO, had no symptoms or showed clear improvement after 48 hours, compared to 48.5% in the placebo group.
¨The Montreal Canadiens are an icon and have been part of Canada's history for over 100 years, being one of the most prize-winning franchises. When they approached Boiron Laboratories to partner with this prestigious institution for season the 2010-2011, I readily accepted," adds Majid Djoudi.
(1)Papp R., Schuback G., Beck E., et als. Oscillococcinum in patients with influenza-like syndromes: a placebo-controlled, double-blind evaluation. British Homeopathic Journal, 1998;87:69-76
ABOUT BOIRON LABORATORIES
World leader in homeopathy, Boiron Laboratories (http://boiron.ca/en/) is best known for its flagship product, Oscillococcinum® - Oscillo®, a leading flu medicine; Camilia, Cocyntal, Coryzalia and Stodal; a line of medicinal products for kids; and Arnica products for muscle injuries and aches. Boiron Laboratories has been committed to developing homeopathic medicines by promoting scientific research and educating physicians and the public for over 75 years worldwide.
Boiron Laboratories have been established in Canada since 1988 with their head office in Saint-Bruno de Montarville, Quebec. Boiron medicines are available in pharmacies, health food stores and department stores throughout Canada. Today, Boiron Laboratories are represented by 4,000 partners, 23 foreign branches, 4 production sites and medicines distributed in over 80 countries.
For further information:
or to schedule an interview with Mr. Majid Djoudi, CEO of Boiron Canada, please contact:
BRIGITTE FILIATRAULT
Brigitte Filiatrault Relations Publiques for Boiron Laboratories
514-521-8216 | Cell. : 514-702-2744
[email protected]
Share this article